AI-Powered Lung Drug Reverses Aging Markers
Rentosertib, a drug developed using artificial intelligence by Insilico Medicine, showed success in reducing biological aging signs in mid-stage studies.
An experimental lung disease drug developed using artificial intelligence technology has revealed the potential to reverse biological aging signs in the body in a new study.
AI-Powered Development
An experimental lung disease drug developed with the help of artificial intelligence was reported to hold promise in reversing biological aging signs, pointing to the potential for the treatment to be used in broader areas.
Research Results and Data
According to the analysis published on Monday in the journal Nature Biotechnology, Insilico Medicine's drug named rentosertib helped lower biological age according to six different aging clock measurements that examine chemical changes in the body.
Comparison with Placebo Group
According to the statement by the company traded on the Hong Kong Stock Exchange, very little change was observed in the biological ages of participants given a placebo across the same aging clocks.